Acute intermittent porphyria is rare inherited metabolic disorder caused by
Abstract
Introduction. Acute intermittent porphyria is rare inherited metabolic disorder caused by decreased level of porphobilinogen deaminase. Subsequently accumulation of byproducts in neural elements causes classic triad of abdominal pain, neurological dysfunction and psychiatric disturbances. Case report. We admitted in our intensive care unit a 22 year old female patient with convulsions, episode of blindness and progresssive development of quadriparesis, bulbar paralysis and respiratory failure twelve days after colon resection in local hospital. Diagnosis was confirmed by high level of porphobilinogen in urine.
Previous use of oral contraceptives, antidepressants and thiopenthal as induction agent for general anesthesia might be a precipitating factors. She was managed conservatively with high carbohydrate intake and human hemin and six months after admission transferred to department of rehabilitation. Conclusion. Early recognized acute intermittent porphyria is cornerstone of positive outcome. Second step is adequate therapy followed by prevention of attacks. However if we look generaly, the disease is a result of enzyme dysfunction of same biosynthetic pathway, but differences in organ affection are from mistakes in different isoenzymes of one enzyme, different processing of mRNA and different microenvironment in cell matrix 1 . Acute intermittent porphyria (AIP) is rare autosomal dominant disorder.
Prevalence in Europe is 1-2 per 100 000 (highest is in Scandinavia with 1 per 1500) 2,3,4 . Hyponatremia, present from the beginning, was treated with 3% saline infusions and specific therapy with 10% and 50% dextrose IV along with enteral feeding and administration of Human hemin (Normosang ® 25mg/ml, Orphan Europe SARL, Puteaux, France) in dose of 4mg/kg/day for four days in a row. Therapy with Normosang® was given on two occasions, after 30 days, and after three months. The first dose led to a minimal improvement in clinical symptoms, while the second dose had a better effect.
Case Report
She was tracheotomised and percutaneous endoscopic gastrostomy has been done. After 160 days of intensive care she was transferred to the department of physical medicine and rehabilitation. The patient was discharge from intensive care with spontaneous breathing, with an act of swallowing and movements in all extremities (Figure 1, Figure 2 ).
Interviewing her parents we found out that at the beginning of the year she had laparoscopic surgery of ovarian cysts and subsequently received advice to take oral contraceptives (one of the main provoking factor). After just a few weeks she leaves stopped the suggested therapy because of nausea and vomiting, apathy and sleepiness.
Three months later, she was hospitalized in a local hospital with significant epigastric pain and vomiting, back pain and constipation that lasts for four days. During hospital stay she has had also suffered from insomnia and hallucinations. Ward doctor consulted a psychiatrist who established diagnosis of somatoform disorder and prescribed her sulpiride (Eglonyl ® , Alkaloid AD, N.Macedonia), one of porphyrinogenic drugs. After series of medical tests and examinations she has been discharged with the diagnosis of biliary gastritis. Next day, at the request of her parents she was admitted to a higher-level hospital in the nearby town due to further worsening of the abdominal pain and the appearance of new symptom-inability to climb the stairs (due to proximal neuropathy). CT scan of abdomen revealed widening of transverse colon which is interpreted as toxic megacolon and she underwent surgery. After twelve days later she was transferred to our hospital.
Discussion
Acute Intermittent Porphyria (AIP) symptomatic is mainly heterozygotes and rarely homozygotes. It is characterized by long latent period and symptoms become manifested after puberty in third and fourth decade of life after exposure to some provoking factor 5 .
There are no cutaneous manifestations. AIP is metabolic disorder caused by deficiency of porfobilinogen deaminase (PBGD). Patients with AIP have acute attacks of neurovisceral symptoms (affection of autonomic nervous system) followed with high level of porphyrin precursors in urine. First presentation of disorder is in 85-95% abdominal pain and in 45% peripheral neuropathy with motor weakness. Exact mechanism of neuronal damage is unknown, one of proposed theory is crystallization of byproducts in neural structures 5, 6 .
Variety of clinical presentation is considerable: abdominal pain, nausea, vomiting, paralytic ileus, urinary retention or incontinence, tachycardia, arterial hypertension, sweating, tremor, postural hypotension, peripheral neuropathy (proximal because of axonal degeneration and demyelination), sensory neuropathy (paresthesias and dysesthesias), cranial neuropathy (VII and X), periodical cortical blindness (caused by vasospasm), epileptiform seizures and rarely bulbar paralysis and death 7, 8 .
Deficiency of PBGD is not enough for clinical manifestation there must be a presence of provoking factors: medications (inductors of P450 cytochrome oxidase), fasting, hormones (progesterone), smoking, alcohol, metabolic stress (infection, surgery, psychological stress) 1 .
Diagnosis is based on clinical presentation and high level of urine porphobilinogen. The most relevant thing is high level of clinical suspicion 9, 10 .
Treatment consists of following steps: review all medications and discontinue any that can exacerbate acute porphyria, restore energy balance using an enteral route if possible if not IV dextrose in dose of 300-400 g/day , hemin 3-4 mg/kg IV, given once daily for four days and prevention of future attacks (treat intercurrent infections and other diseases promptly) 11, 12 .
Chronic complications are hepatocellular carcinoma and renal failure 13, 14 . 
Conclusion

